About Dihydroergotamine Mysilate
            
            Class: | Ergot alkaloid  
Use: | Treatment of acute migraine attacks and cluster headaches  
Adult dose: | 1 mg (1 ml) subcutaneously or intramuscularly; may repeat after 1 hour if needed, not to exceed 3 mg in 24 hours  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | Nausea, vomiting, abdominal pain, dizziness, fatigue, and injection site reactions  
Contraindications: | Hypersensitivity to dihydroergotamine or 
         
        
            
                
                
                    
                        Drug Class
                    
                    Ergot alkaloid
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of acute migraine attacks and cluster headaches
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Apollo Pharmaceuticals Inc, United States of America
                    
                    
                    Package Size
                    1ml Ampoule X 5
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2185.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1 mg (1 ml) subcutaneously or intramuscularly; may repeat after 1 hour if needed, not to exceed 3 mg in 24 hours
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, abdominal pain, dizziness, fatigue, and injection site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to dihydroergotamine or other ergot alkaloids; history of coronary artery disease, peripheral vascular disease, uncontrolled hypertension, pregnancy, and concurrent use of potent CYP3A4 inhibitors
         
        
        
            
                Important Warnings
            
            Risk of ergotism (severe vasoconstriction), cardiovascular events, and serotonin syndrome when used with other serotonergic drugs; monitor for signs of ischemia and discontinue if symptoms occur
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.